This Funding Opportunity Announcement (FOA) from the INCLUDE project invites applications for new exploratory and developmental research projects. This grant is for addressing critical needs in Down syndrome research, specifically focusing on co-occurring conditions across the lifespan, aligning with INCLUDE’s objectives. Researchers are encouraged to propose studies that assess the feasibility of novel investigation areas, test new experimental systems, or apply existing methodologies innovatively to explore new scientific areas. While these projects may involve significant risk, they hold the potential to lead to breakthroughs, develop novel techniques, agents, methodologies, models, or applications. The ultimate goal is to generate a major impact on biomedical, behavioral, or clinical research related to Down syndrome.
Opportunity ID: 335929
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-OD-21-007 |
Funding Opportunity Title: | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 24, 2021 |
Last Updated Date: | Sep 24, 2021 |
Original Closing Date for Applications: | Nov 03, 2022 |
Current Closing Date for Applications: | Nov 03, 2022 |
Archive Date: | Dec 09, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Public housing authorities/Indian housing authorities County governments Independent school districts Private institutions of higher education Small businesses Special district governments Native American tribal governments (Federally recognized) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of new exploratory and developmental research projects that address critical needs for Down syndrome projects, as articulated in the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) project objectives. For example, such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research. Another example could include the unique and innovative use of an existing methodology to explore a new scientific area. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-007.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 335929 Full Announcement-RFA-OD-21-007 -> RFA-OD-21-007-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00269064 | Oct 03, 2021 | Jan 24, 2022 | View | |
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270343 | Nov 16, 2021 | Nov 03, 2022 | View | |
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278185 | Nov 08, 2022 | Jul 03, 2024 | View |
Package 1
Mandatory forms
335929 RR_SF424_2_0-2.0.pdf
335929 PHS398_CoverPageSupplement_5_0-5.0.pdf
335929 RR_OtherProjectInfo_1_4-1.4.pdf
335929 PerformanceSite_2_0-2.0.pdf
335929 RR_KeyPersonExpanded_2_0-2.0.pdf
335929 PHS398_ResearchPlan_4_0-4.0.pdf
335929 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
335929 RR_Budget_1_4-1.4.pdf
335929 RR_SubawardBudget30_1_4-1.4.pdf
335929 PHS398_ModularBudget_1_2-1.2.pdf
335929 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
335929 RR_SF424_5_0-5.0.pdf
335929 PHS398_CoverPageSupplement_5_0-5.0.pdf
335929 RR_OtherProjectInfo_1_4-1.4.pdf
335929 PerformanceSite_4_0-4.0.pdf
335929 RR_KeyPersonExpanded_4_0-4.0.pdf
335929 PHS398_ResearchPlan_4_0-4.0.pdf
335929 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335929 RR_Budget_3_0-3.0.pdf
335929 RR_SubawardBudget30_3_0-3.0.pdf
335929 PHS398_ModularBudget_1_2-1.2.pdf
335929 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
335929 RR_SF424_5_0-5.0.pdf
335929 PHS398_CoverPageSupplement_5_0-5.0.pdf
335929 RR_OtherProjectInfo_1_4-1.4.pdf
335929 PerformanceSite_4_0-4.0.pdf
335929 RR_KeyPersonExpanded_4_0-4.0.pdf
335929 PHS398_ResearchPlan_5_0-5.0.pdf
335929 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335929 RR_Budget_3_0-3.0.pdf
335929 RR_SubawardBudget30_3_0-3.0.pdf
335929 PHS398_ModularBudget_1_2-1.2.pdf
335929 PHS_AssignmentRequestForm_3_0-3.0.pdf